Hyper-low-density lipoprotein (LDL) cholesterolemia

Clinical trials for Hyper-low-density lipoprotein (LDL) cholesterolemia explained in plain language.

Never miss a new study

Get alerted when new Hyper-low-density lipoprotein (LDL) cholesterolemia trials appear

Sign up with your email to follow new studies for Hyper-low-density lipoprotein (LDL) cholesterolemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New hope for high cholesterol: Statin-Free drug shows promise in Year-Long study

Disease control Completed

This study tested a daily pill called ETC-1002 in 130 adults with very high LDL ("bad") cholesterol who either didn't respond well to statins or had side effects from them. Over 52 weeks, researchers checked how safe the drug was and how much it lowered cholesterol. The goal was …

Matched conditions: HYPER-LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROLEMIA

Phase 3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC

Hyper-low-density lipoprotein (LDL) cholesterolemia

Get alerted when new Hyper-low-density lipoprotein (LDL) cholesterolemia trials appear

New hope for high cholesterol: Statin-Free drug shows promise in Year-Long study